|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
17
|
|
pubmed:dateCreated |
2001-9-4
|
|
pubmed:abstractText |
Most anticancer drugs are dosed based on body-surface area (BSA) to reduce interindividual variability of drug effects. We evaluated the relevance of this concept for cisplatin by analyzing cisplatin pharmacokinetics obtained in prospective studies in a large patient population.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
19
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
3733-9
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:11533095-Adult,
pubmed-meshheading:11533095-Aged,
pubmed-meshheading:11533095-Analysis of Variance,
pubmed-meshheading:11533095-Antineoplastic Agents,
pubmed-meshheading:11533095-Body Surface Area,
pubmed-meshheading:11533095-Cisplatin,
pubmed-meshheading:11533095-Dose-Response Relationship, Drug,
pubmed-meshheading:11533095-Female,
pubmed-meshheading:11533095-Humans,
pubmed-meshheading:11533095-Linear Models,
pubmed-meshheading:11533095-Male,
pubmed-meshheading:11533095-Metabolic Clearance Rate,
pubmed-meshheading:11533095-Middle Aged,
pubmed-meshheading:11533095-Prospective Studies,
pubmed-meshheading:11533095-Sex Factors,
pubmed-meshheading:11533095-Statistics, Nonparametric
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Body-surface area-based dosing does not increase accuracy of predicting cisplatin exposure.
|
|
pubmed:affiliation |
Department of Medical Oncology, Rotterdam Cancer Institute (Daniel den Hoed Kliniek), Rotterdam, The Netherlands.
|
|
pubmed:publicationType |
Journal Article
|
